Law Viewer

Back Home

ENFORCEMENT DECREE OF THE INFECTIOUS DISEASE CONTROL AND PREVENTION ACT

Wholly Amended by Presidential Decree No. 22564, Dec. 29, 2010

Amended by Presidential Decree No. 23356, Dec. 8, 2011

Presidential Decree No. 24454, Mar. 23, 2013

Presidential Decree No. 25448, Jul. 7, 2014

Presidential Decree No. 25532, Aug. 6, 2014

Presidential Decree No. 26024, Jan. 6, 2015

Presidential Decree No. 26865, Jan. 6, 2016

Presidential Decree No. 26916, Jan. 19, 2016

Presidential Decree No. 27277, jun. 28, 2016

Presidential Decree No. 27445, Aug. 11, 2016

Presidential Decree No. 27971, Mar. 29, 2017

Presidential Decree No. 28070, May 29, 2017

 Article 1 (Purpose)
The purpose of this Decree is to prescribe matters delegated by the Infectious Disease Control and Prevention Act and other matters necessary for the enforcement of said Act.
 Article 1-2 (Establishment, Operation, etc. of Organizations for Supporting Infectious Disease Control Projects)
(1) Under Article 8 (1) of the Infectious Disease Control and Prevention Act (hereinafter referred to as the "Act"), the Central Organization for Supporting Infectious Disease Control Projects shall be established in the Ministry of Health and Welfare and City/Do organizations for supporting infectious disease projects in Special Metropolitan Cities, Metropolitan Cities, Dos and Special Self-Governing Provinces (hereinafter referred to as "City/Do").
(2) Members of the Central Organization Supporting Infectious Disease Control Projects shall be commissioned by the Minister of Health and Welfare, from among persons who fall under any of the followings:
1. A person who has worked in infectious disease-related areas as a member of medical personnel defined in subparagraph 1 of Article 2 of the Medical Service Act;
2. A person who has worked in infectious disease-related areas at universities prescribed in the Higher Education Act or public institutions prescribed in the Act on the Management of Public Institutions;
3. A person with abundant knowledge and experience in the prevention and control of infectious diseases;
4. A person with abundant knowledge and experience in the areas of epidemiological investigation, prevention of epidemics, etc.;
5. A person the Minister of Health and Welfare deems necessary for supporting infectious disease control projects.
(3) If necessary for conducting of its duties, the Central Organization for Supporting Infectious Disease Control Projects may request the relevant institutions, organizations, experts, etc. to submit materials, opinions, etc.
(4) The Central Organization for Supporting Infectious Disease Control Projects shall report the status of its activities, etc. to the Minister of Health and Welfare as prescribed by the Minister of Health and Welfare every half year.
(5) The Minister of Health and Welfare may provide the Central Organization for Supporting Infectious Disease Control Projects with subsidies to cover the following costs within budgetary limits:
1. Costs incurred in the collection of materials, investigation, analysis, consulting, etc.;
2. Travel expenses, allowances, etc. incurred in the promotion of domestic and international cooperative projects;
3. Other expenses the Minister of Health and Welfare deems particularly necessary for conducting duties.
(6) Except as otherwise provided for in paragraphs (2) through (5), detailed matters necessary for establishing, operating, subsidizing etc. the Central Organization for Supporting Infectious Disease Control Projects, shall be determined by the Minister of Health and Welfare.
(7) Paragraphs (2) through (6) shall apply mutatis mutandis to commissioning of members, requests for submission of materials, reporting on the status of activities, subsidization, etc. of City/Do organizations for supporting infectious disease control projects. In such cases, the "Minister of Health and Welfare," and the "Central Organization for Supporting Infectious Disease Control Projects," shall be construed as a "Special Metropolitan City Mayor, Metropolitan City Mayor, Do Governor, or Special Self-Governing Province Governor (hereinafter referred to as a "City Mayor/Do Governor") and a "City/Do organization for supporting infectious disease control projects," respectively.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 1-3 (Designation, etc. of Infectious Disease Specialty Hospitals)
(1) A medical institution (referring to a medical institution prescribed in Article 3 of the Medical Service Act: hereinafter referred to as "medical institution") eligible to be designated as an infectious disease speciality hospital prescribed in Article 8-2 (1) of the Act (hereinafter referred to as the "Central Infectious Disease Hospital"), shall be a medical institution the Minister of Health and Welfare determines and publicly announces, among general hospitals or superior general hospitals prescribed in Article 3-3 or 3-4 of the Medical Service Act.
(2) The standards for designation of the Central Infectious Disease Hospital are as prescribed in attached Table 1.
(3) Where the Minister of Health and Welfare designates the Central Infectious Disease Hospital, he/she may apply conditions to the standards for designation, conduct of duties, etc. thereof.
(4) Where the Minister of Health and Welfare has designated the Central Infectious Disease Hospital, he/she shall deliver a certificate of designation and post the details of such designation on the website of the Ministry of Health and Welfare.
(5) The Central Infectious Disease Hospital shall report the status of performance of duties, etc. to the Minister of Health and Welfare each quarter as prescribed by the Minister of Health and Welfare.
(6) The Minister of Health and Welfare may subsidize the Central Infectious Disease Hospital for building costs, operating costs, installation costs, etc., in consultation with the Minister of Strategy and Finance under Article 8-2 (3) of the Act.
(7) Except as otherwise provided for in paragraphs (3) through (6), detailed matters necessary for procedures for designation, subsidies for expenses, etc. of the Central Infectious Disease Hospital, shall be determined and announced by the Minister of Health and Welfare.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 1-4 (Designation of Regional Infectious Disease Speciality Hospitals)
(1) A medical institution eligible to be designated as a regional infectious disease specialty hospital under Article 8-2 (2) of the Act (hereinafter referred to as a "regional infectious disease hospital"), shall be a medical institution the Minister of Health and Welfare determines and publicly announces, among general hospitals or superior general hospitals prescribed in Article 3-3 or 3-4 of the Medical Service Act.
(2) The standards for designating regional infectious disease hospitals are as prescribed in attached Table 1-2.
(3) Where the Minister of Health and Welfare designates a regional infectious disease hospital under Article 8-2 (2) of the Act, he/she shall consider the following matters comprehensively:
1. The level of distribution of medical service resources in the relevant region;
2. The population and the range of habitate of the relevant region;
3. The frequency of outbreak and the level of control of infectious diseases in the relevant region;
4. The vicinity to harbors, airports, etc. in the relevant region;
5. Other matters the Minister of Health and Welfare deems particularly necessary in connection with the control of infectious diseases by region.
(4) If necessary to designate a regional infectious disease hospital, the Minister of Health and Welfare may listen to the opinions of the heads of local governments, of the relevant public institutions or organizations, etc. or request the same to submit materials.
(5) Article 1-3 (3) through (7) shall apply mutatis mutandis to the public announcement of detailed matters necessary for the addition of conditions of designation, delivery of certificates of designation, public announcement of designation, reporting on the status of performance of duties, subsidies for costs, procedures for designation, etc. of regional infectious disease hospitals.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 1-5 (Formulation of Measures for Controlling Resistant Bacteria)
(1) Where the Minister of Health and Welfare intends to change important matters the Minister of Health and Welfare determines among the matters included in the measures for controlling resistant bacteria prescribed in Article 8-3 (1) of the Act (hereinafter referred to as "measures for controlling resistant bacteria"), he/she shall submit such changes for deliberation by the Infectious Disease Control Committee prescribed in Article 9 (1) of the Act.
(2) Where the Minister of Health and Welfare formulates or changes measures for controlling resistant bacteria, he/she shall post such measures on the website of the Ministry of Health and Welfare and inform the heads of the relevant central administrative agencies, the President of the Health Insurance Review and Assessment Service under the National Health Insurance Act and the heads of other resistant bacteria-related institutions, corporations and organizations of the details thereof.
(3) Except as otherwise provided for in paragraphs (1) and (2), detailed matters necessary for the formulation and change of measures for controlling resistant bacteria shall be determined by the Minister of Health and Welfare.
[This Article Newly Inserted by Presidential Decree No. 28070, May 29, 2017]
 Article 2 (Duties, and Terms of Office, of Members of Infectious Disease Control Committee)
(1) The Chairperson of the Infectious Disease Control Committee (hereinafter referred to as the “Committee”) established under Article 9 (1) of the Act, shall represent the Committee and exercise general control over the administrative affairs thereof. <Amended by Presidential Decree No. 27277, Jun. 28, 2016>
(2) The vice-chairperson of the Committee shall assist the Chairperson and act on the Chairperson's behalf if the Chairperson is unable to perform any of his/her duties due to an extenuating circumstance.
(3) The term of office of any commissioned member of the Committee shall be two years.
(4) If a vacancy occurs in the office of Committee member, the term of office of a member filling the vacancy shall be the remainder of his/her predecessor’s term of office.
 Article 3 (Meetings)
(1) Committee meetings shall be convened upon request by the Minister of Health and Welfare, by a majority of the members thereof, or by the Chairperson when he/she deems necessary.
(2) A majority of the members of the Committee shall constitute a quorum at Committee meetings and resolutions shall be passed with the concurrent vote of a majority of members present.
(3) The Chairperson of the Committee shall report the resolutions adopted by the Committee to the Minister of Health and Welfare.
(4) If deemed necessary for conducting its affairs, the Committee may request relevant public officials or experts to appear before the Committee to state their opinions.
 Article 4 (Executive Secretary)
The Committee shall have one executive secretary to administer the clerical work thereof, who shall be appointed by the Chairperson, from among public officials of the Ministry of Health and Welfare.
 Article 5 (Payment of Allowances, etc.)
A member who attends a Committee meeting may be paid allowances and reimbursed for travel expenses, within budgetary limits: Provided, That this shall not apply where a member who is a public official attends a Committee meeting directly in connection with any of his/her official duties.
 Article 6 (Detailed Operating Rules)
Except as otherwise expressly provided for in this Decree, matters necessary for operating the Committee shall be determined by the Chairperson, following a resolution by the Committee.
 Article 7 (Organization of Advisory Committees)
(1) Pursuant to Article 10 (3) of the Act, the Committee shall establish the following advisory committees for each field: <Amended by Presidential Decree No. 26024, Jan. 6, 2015; Presidential Decree No. 28070, May 29, 2017>
1. The advisory committee on vaccination;
2. The advisory committee on vaccination injury compensation;
3. The advisory committee on acquired immunodeficiency syndrome;
4. The advisory committee on tuberculosis;
5. The advisory committee on epidemiological investigation;
6. The advisory committee on zoonoses;
7. The advisory committee on crisis control protocols against infectious diseases;
8. The advisory research and planning committee on infectious diseases;
9. The advisory committee on antibiotic resistance.
(2) Each advisory committee shall be comprised of not exceeding fifteen members, including one chairperson.
(3) The chairperson of each advisory committee shall be appointed by the Chairperson of the Committee, from among Committee members.
(4) Members of each advisory committee shall be appointed by the Chairperson of the Committee, from among Committee members, or commissioned by the Chairperson of the Committee, from among those recommended by the relevant academic society or organization or by Committee members.
 Article 8 (Meetings and Operation of Advisory Committees)
(1) Meetings of an advisory committee shall be convened upon request by the Chairperson of the Committee, by a majority of the members of the advisory committee, or by the chairperson of the advisory committee when he/she deems necessary.
(2) A majority of the members of an advisory committee shall constitute a quorum at committee meetings and resolutions shall be passed with the concurrent vote of a majority of members present.
(3) The chairperson of an advisory committee shall report the resolutions deliberated on and adopted by the advisory committee to the Chairperson of the Committee. <Amended by Presidential Decree No. 26024, Jan. 6, 2015>
(4) Except as otherwise expressly provided for in this Decree, matters necessary for operating each advisory committee shall be determined by the chairperson of the advisory committee, following a resolution by the advisory committee.
 Article 9 (Other Zoonoses)
“Other zoonoses prescribed by Presidential Decree” in Article 14 (1) 4 of the Act, means animal influenza. <Amended by Presidential Decree No. 26865, Jan. 6, 2016>
 Article 10 (Public Institutions)
“Public institutions prescribed by Presidential Decree” in the former part of Article 16 (7) of the Act, means the Health Insurance Review and Assessment Service and the National Health Insurance Service established under the National Health Insurance Act. <Amended by Presidential Decree No. 26865, Jan. 6, 2016>
 Article 11 (Information to be Provided)
Information requestable under Article 16 (7) of the Act, may include the following: <Amended by Presidential Decree No. 26865, Jan. 6, 2016>
1. The name, resident registration number, gender, address, telephone number, occupation, name of infectious disease, date of onset of symptoms, and date patient diagnosed with an infectious disease, patient suspected of an infectious disease, or pathogen carrier (hereinafter referred to as “patient, etc. with an infectious disease”);
2. The name, location, and telephone number of the medical institution that diagnosed the case of a patient, etc. with an infectious disease, and the name of the doctor who made such diagnosis.
 Article 12 (Details of Epidemiological Investigations)
(1) Matters to be identified through epidemiological investigations under Article 18 (1) of the Act, shall be as follows:
1. The personal information of patients, etc. with an infectious disease;
2. The date and place where a patient, etc. was infected with an infectious disease;
3. The cause and route of infection for an infectious disease;
4. The medical record of a patient, etc. with an infectious disease;
5. Other matters necessary to reveal the cause of an infectious disease.
(2) Matters to be identified through epidemiological investigations under Article 29 of the Act, shall be as follows:
1. The personal information of persons showing adverse reactions to vaccinations;
2. The vaccination service institution, date of vaccination, and details of vaccination;
3. The record of medical treatment for adverse reactions to vaccinations;
4. The details of vaccines;
5. Other matters necessary to reveal the causes of adverse reactions to vaccinations.
 Article 13 (Timing of Epidemiological Investigations)
Epidemiological investigations specified in Articles 18 (1) and 29 of the Act shall be conducted as necessary, as follows: <Amended by Presidential Decree No. 27277, Jun. 28, 2016>
1. Where the Director of the Korea Centers for Disease Control and Prevention is required to conduct an epidemiological investigation:
(a) Where the epidemiological investigation is to be conducted simultaneously in at least two Cities/Dos;
(b) Where an urgent investigation is necessary, as to the outbreak or prevalence of an infectious disease or adverse reactions to vaccinations;
(c) Where deemed that an epidemiological investigation conducted by a City Mayor/Do Governor is insufficient or it is impracticable for a Mayor/Do Governor to conduct an epidemiological investigation;
2. Where a Mayor/Do Governor or the head of a Si/Gun/Gu (referring to an autonomous Gu; hereinafter the same shall apply) is required to conduct an epidemiological investigation:
(a) Where an infectious disease is likely to occur and prevail within his/her jurisdiction;
(b) Where an infectious disease is likely to occur and prevail outside his/her jurisdiction, but suspected to have an epidemiological link within his/her jurisdiction;
(c) Where a case of an adverse reaction to a vaccination is found within his/her jurisdiction, thus making it necessary to conduct an investigation to identify the cause.
 Article 14 (Methods of Epidemiological Investigation)
The methods of conducting epidemiological investigations under Articles 18 (1) and 29 of the Act shall be as set forth in attached Table 1-3. <Amended by Presidential Decree No. 27277, Jun. 28, 2016>
 Article 15 (Composition of Epidemiological Investigation Teams)
(1) To conduct an epidemiological investigation under Articles 18 (1) and 29 of the Act, a central epidemiological investigation team shall be established in the Korea Centers for Disease Control and Prevention, a City/Do epidemiological investigation team in a City/Do, and a Si/Gun/Gu epidemiological investigation team in a Si/Gun/Gu (referring to an autonomous Gu; hereinafter the same shall apply).
(2) The central epidemiological investigation team shall be comprised of at least 30 members; City/Do epidemiological investigation teams and Si/Gun/Gu epidemiological investigation teams, respectively, shall be comprised of not exceeding 20 members; and an epidemic control officer appointed under Article 60 of the Act or an epidemiological investigative officer appointed under Article 60-2 of the Act, shall serve as the chief of each epidemiological investigation team. <Amended by Presidential Decree No. 26865, Jan. 6, 2016>
(3) Members of each epidemiological investigation team shall be appointed or commissioned by the Director of the Korea Centers for Disease Control and Prevention, a Mayor/Do Governor, or the head of a Si/Gun/Gu, respectively, from among the following: <Amended by Presidential Decree No. 26865, Jan. 6, 2016>
1. Public officials who take charge of epidemic control, epidemiological investigations, or vaccination services;
2. Epidemiological investigative officers specified in Article 60-2 of the Act;
4. Medical personnel defined in Article 2 (1) of the Medical Service Act;
5. Other experts in the field of infectious diseases or similar.
(4) Each epidemiological investigation team shall be divided into two sections covering the area of infectious diseases and the area of adverse reactions to vaccinations, and matters necessary to operate those sections, shall be determined by the Director of the Korea Centers for Disease Control and Prevention.
 Article 16 (Functions, etc. of Epidemiological Investigation Teams)
(1) The functions of each epidemiological investigation team shall be as follows:
1. The central epidemiological investigation team:
(a) Formulating, implementing, and evaluating an epidemiological investigation plan;
(b) Developing the standards and methods for conducting epidemiological investigations;
(c) Providing education and training for City/Do epidemiological investigation teams and Si/Gun/Gu epidemiological investigation teams;
(d) Conducting epidemiological research on infectious diseases;
(e) Collecting, analyzing, and providing for both the cases of outbreak and prevalence of infectious diseases and the cases of adverse reactions to vaccinations;
(f) Providing technical guidance for and evaluation of City/Do epidemiological investigation teams;
2. City/Do epidemiological investigation teams:
(a) Formulating, implementing, and evaluating an epidemiological investigation plan for each jurisdiction;
(b) Developing detailed standards and methods for conducting epidemiological investigations in each jurisdiction;
(c) Reporting the findings of epidemiological investigations in each jurisdiction, to the central epidemiological investigation team;
(d) Collecting, analyzing, and providing for both the cases of outbreak and prevalence of infectious diseases, and for the cases of adverse reactions to vaccinations in each jurisdiction;
(e) Providing technical guidance for and evaluation of Si/Gun/Gu epidemiological investigation teams;
3. Si/Gun/Gu epidemiological investigation teams:
(a) Formulating and implementing an epidemiological investigation plan for each jurisdiction;
(b) Reporting the findings of epidemiological investigations in each jurisdiction, to the relevant City/Do epidemiological investigation team;
(c) Collecting, analyzing, and providing for both the cases of outbreak and prevalence of infectious diseases and the cases of adverse reactions to vaccinations in each jurisdiction.
(2) Each epidemiological investigation team member who conducts an epidemiological investigation shall carry a certificate of epidemiological investigator prescribed by Ordinance of the Ministry of Health and Welfare, and produce it to interested parties.
(3) The Director of the Korea Centers for Disease Control and Prevention, a Mayor/Do Governor, or the head of a Si/Gun/Gu may pay allowances and reimburse travel expenses incurred in epidemiological investigative activities, within budgetary limits, to epidemiological investigation team members.
 Article 16-2 (Institutions or Organizations Required to Present Materials)
“Institution or organization, etc. prescribed by Presidential Decree” in Article 18-4 (1) of the Act, means the following: <Amended by Presidential Decree No. 27277, Jun. 28, 2016>
1. A medical institution;
2. The National Health Insurance Service established under Article 13 of the National Health Insurance Act;
3. The Health Insurance Review and Assessment Service established under Article 62 of the National Health Insurance Act.
[This Article Newly Inserted by Presidential Decree No. 26865, Jan. 6, 2016]
 Article 16-3 (Extent of Request for Assistance, etc.)
The Minister of Health and Welfare may request the head of a relevant central administrative agency to dispatch its personnel and provide goods necessary for conducting epidemiological investigations, to manage persons and institutions subject to epidemiological investigations, to conduct examinations and analyze information for identifying the source and route of infection, and provide other necessary assistance, pursuant to Article 18-4 (2) of the Act.
[This Article Newly Inserted by Presidential Decree No. 26865, Jan. 6, 2016]
 Article 17 (Permit Requirements for Introducing High-Risk Pathogens)
A person who intends to obtain a permit to introduce high-risk pathogens under Article 22 (1) of the Act, shall satisfy each of the following requirements:
1. To establish and operate research facilities permitted or reported by class of safety management under Article 22 (1) of the Transboundary Movement, etc. of Living Modified Organisms Act;
2. To formulate a plan for safe transportation of high-risk pathogens and emergency response;
3. To employ a manager who takes exclusive charge of high-risk pathogens.
 Article 18 (Matters to be Reported in Changing Permit for Introducing High-Risk Pathogens)
“Insignificant matters prescribed by Presidential Decree” in the proviso to Article 22 (2) of the Act, means each of the following:
1. The name (including the name of a legal entity) and address of the person permitted to introduce high-risk pathogens;
2. The name and position of the manager who takes exclusive charge of high-risk pathogens.
 Article 19 (Designation of Place to Acquire High-Risk Pathogens)
A person who intends to acquire and transfer high-risk pathogens under Article 22 (3) of the Act, shall designate the place of acquisition from among those determined by the Minister of Health and Welfare.
 Article 20 (Entrustment of Vaccination Services)
(1) A Special Self-Governing Province Governor or the head of a Si/Gun/Gu may entrust vaccination services beyond the capability of public health centers or for residents, etc. having difficulty visiting public health centers, under Articles 24 (2) and 25 (2) of the Act, to medical institutions designated by the Special Self-Governing Province Governor or the head of the Si/Gun/Gu, from among general hospitals, hospitals, convalescent hospitals (limited to those in which medical services are rendered by doctors), and medical clinics specified in Article 3 of the Medical Service Act. In such cases, the Special Self-Governing Province Governor or the head of the Si/Gun/Gu shall publicly announce the institutions so entrusted.
(2) When entrusting vaccination services under paragraph (1), the Special Self-Governing Province Governor or the head of the Si/Gun/Gu shall prepare an entrustment contract providing for each of the following: <Newly Inserted by Presidential Decree No. 26024, Jan. 6, 2015>
1. The scope of the vaccination services entrusted;
2. The period for the entrustment contract;
3. The terms and conditions of the entrustment contract;
4. The cancellation of the entrustment contract.
(3) Matters necessary for the procedures, etc. for calculating and refunding vaccination expenses incurred in relation to vaccination services entrusted under paragraph (1), shall be determined and publicly announced by the Minister of Health and Welfare. <Amended by Presidential Decree No. 26024, Jan. 6, 2015>
 Article 20-2 (Pre-Checking of Vaccination Records)
The head of each public health clinic that provides vaccination services under Articles 24 (1) and 25 (1) of the Act and the head of each medical institution entrusted with vaccination services under Article 24 (2) (including where the said Article applies mutatis mutandis in Article 25 (2) of the Act) of the Act (hereinafter referred to as the "head of each public health clinic, etc.") shall obtain written consent from those who intend to be vaccinated or from the legal representatives thereof on the following matters under the main sentence of Article 26-2 (1) of the Act:
1. The fact that they have confirmed the details of the vaccination;
2. The method of confirming the details of the vaccination.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 21 (Organization, etc. of Vaccination Injury Investigation Teams)
(1) A vaccination injury investigation team prescribed under Article 30 (2) of the Act (hereinafter referred to as “injury investigation team”) shall be comprised of not exceeding ten members.
(2) Members of the injury investigation team shall be appointed or commissioned by the Director of the Korea Centers for Disease Control and Prevention, from among public officials under his/her control or from among the following:
1. Experts in the field of vaccination and adverse reactions to vaccinations;
2. Medical personnel defined in Article 2 (1) of the Medical Service Act.
(3) The injury investigation team shall investigate the following matters and report the findings therefrom to the advisory committee on vaccination injury compensation:
1. The evaluation and supplementation of the findings of a basic investigation submitted by a Mayor/Do Governor under Article 31 (2);
2. The intention or negligence on the part of a third party provided for in Article 72 (1) of the Act;
3. Other matters determined by the advisory committee on vaccination injury compensation in relation to vaccination injury compensation.
(4) An injury investigation team member who conducts an injury investigation under paragraph (3), shall carry a certificate of vaccination injury investigator prescribed by Ordinance of the Ministry of Health and Welfare, and produce it to interested parties.
(5) The Director of the Korea Centers for Disease Control and Prevention may pay allowances and reimburse travel expenses incurred in conducting injury investigations, within budgetary limits, to injury investigation team members.
(6) Detailed matters for operating the injury investigation team shall be determined by the Director of the Korea Centers for Disease Control and Prevention, following a resolution by the advisory committee on vaccination injury compensation.
 Article 21-2 (Personal Information, etc. of Persons Eligible for Vaccination)
(1) The personal information details of those eligible for vaccination which the Minister of Health and Welfare may request from the relevant institutions and organizations under Article 33-2 (2) 1 of the Act, are as follows:
1. Where a person eligible for vaccination is a national: The following materials:
(a) The name, resident registration number and address of a person eligible for vaccination;
(b) The following details on to which a person eligible for vaccination belongs:
(i) Details of the school prescribed in Article 2 of the Elementary and Secondary Education Act, to which a person eligible for vaccination belongs;
(ii) Details of the kindergarten prescribed in subparagraph 2 of Article 2 of the Early Childhood Education Act to which a person eligible for vaccination belongs;
(iii) Details of the child care center prescribed in subparagraph 3 of Article 2 of the Infant Care Act to which a person eligible for vaccination belongs;
(iv) Details of the child welfare facility prescribed in subparagraph 10 of Article 3 of the Child Welfare Act to which a person eligible for vaccination belongs;
(c) The following Details of a person eligible for vaccination:
(i) Whether a person eligible for vaccination is a child with disabilities prescribed in subparagraph 1 of Article 2 of the Act on Welfare Support for Children with Disabilities;
(ii) Whether a person eligible for vaccination is a member of a multicultural family prescribed in subparagraph 1 of Article 2 of the Multicultural Families Support Act;
(iii) Whether a person eligible for vaccination is a recipient prescribed in subparagraph 2 of Article 2 of the National Basic Living Security Act (including persons of the second lowest income bracket prescribed in subparagraph 10 of the same Article) or a child of such recipient;
2. Where a person eligible for vaccination is a foreigner or a foreign nationality Korean: The following materials:
(a) Information on the registration of aliens prescribed in Article 31 of the Immigration Act;
(b) Information on reporting on the place of residence in Korea of a foreign nationality Korean prescribed in Article 6 of the Act on the Immigration and Legal Status of Overseas Koreans;
3. Other information on the personal information of those eligible for vaccination, which the Minister of Health and Welfare publicly announces in recognition that such information is particularly necessary in connection with conducting vaccination.
(2) Materials the Minister of Health and Welfare may request from the relevant institutions and organizations as materials necessary for vaccination under Article 33-2 (2) 3 of the Act are as follows:
1. Information on the establishment of a medical institution entrusted with vaccination services under Article 24 (2) of the Act (including where the said Article applies mutatis mutandis in Article 25 (2) of the Act);
2. The details of a request for compensation for damage caused by vaccination;
3. Information on the control, etc. of diseases or illness, or infectious diseases for which vaccination is impracticable.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 21-3 (Input of Vaccination Information)
Where the head of a public health clinic, etc. provides a vaccination service, under Article 33-2 (3) of the Act, he/she shall input the following information into the Integrated Vaccination Management System prescribed in paragraph (1) of the same Article (hereinafter referred to as the "integrated management system") without delay:
1. The following information on persons vaccinated:
(a) Name;
(b) Resident registration number: Provided, That where the person vaccinated is a foreigner or a foreign nationality Korean, it refers to the foreigner registration number or the reporting number of the place of residence in Korea;
2. The following information on the details of vaccination:
(a) Name of vaccination;
(b) Number of vaccination;
(c) Date/month/year of vaccination;
(d) Name of the vaccine used in vaccination;
(e) Names of the doctor who made a prior diagnosis and the doctor who vaccinated.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 21-4 (Provision, etc. of Details of Vaccination)
(1) Where the Minister of Health and Welfare provides the parents of children eligible for vaccination with the details of the vaccination under the former part of Article 33-2 (4) of the Act, he/she shall do so by the method of reading by utilizing the integrated management system: Provided, That where the Minister of Health and Welfare deems it necessary, such details may be provided by text message, electronic mail, telephone, mail or other methods equivalent thereto.
(2) Where the Minister of Health and Welfare issues a certificate of vaccination under the former part of Article 33-2 (4) of the Act, he/she may issue such certificate directly from the integrated management system as prescribed by the Minister of Health and Welfare or issue such certificate through an electronic civil petition window prescribed in Article 9 (3) of the Electronic Government Act.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 22 (Procedures, etc. for Formulating Crisis Control Protocols against Infectious Diseases)
(1) The Minister of Health and Welfare may request relevant administrative agencies, local governments, public institutions under Article 4 of the Act on the Management of Public Institutions, etc. to submit materials to formulate crisis control protocols against infectious diseases under Article 34 (1) of the Act.
(2) The Minister of Health and Welfare shall notify the heads of the relevant central administrative agencies of the crisis control protocols against infectious diseases formulated under Article 34 (1) of the Act.
 Article 23 (Methods, Procedures, etc. for Home-Care and Inpatient Treatment)
Methods, procedures, etc. for home-care and inpatient treatment under Article 41 (4) of the Act shall be as prescribed in attached Table 2.
 Article 23-2 (Providing Subsidies, etc. for Costs for Paid Leave)
(1) Subsidies for paid leave provided to business owners under Article 41-2 (3) of the Act shall be in the amount calculated by multiplying the amount the Minister of Health and Welfare publicly announces in consultation with the Minister of Strategy and Finance by the period during which a laborer is hospitalized or isolated under statutes.
(2) Any business owner who intends to be subsidized under Article 41-2 (3) of the Act shall file a written application (including written applications in electronic documents) prescribed by Ordinance of the Ministry of Health and Welfare with the Minister of Health and Welfare along with the following documents (including electronic documents):
1. Documents verifying the fact that a laborer is hospitalized or isolated and the period of such hospitalization or isolation;
2. Documents evidencing that a laborer continues to hold office, such as proof of employment;
3, Documents evidencing that the business owner has given a paid leave to laborers, such as a pay slip;
4. Other documents the Minister of Health and Welfare recognizes to be particularly necessary to provide subsidies for paid leave.
(3) Where the Minister of Health and Welfare receives a written application prescribed in paragraph (2), he/she shall verify the certificate of business registration through the joint use of administrative information under Article 36 (1) of the Electronic Government Act: Provided, That where the business owner disagrees therewith, he/she shall require the business owner attach such certificate to the written application.
(4) Where the Minister of Health and Welfare receives a written application prescribed in paragraph (2), he/she shall determine the possibility of providing subsidies for paid leave and the amount of subsidies and inform the relevant business owner thereof in writing.
(5) Except as otherwise provided for in paragraphs (2) through (4), matters necessary for procedures for applying for subsidies for paid leave, notification of the results thereof, etc. shall be prescribed by Ordinance of the Ministry of Health and Welfare.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 23-3 (Designation of Infectious Disease Control Institutions for Isolation, etc. of Patients with Infectious Diseases, etc.)
(1) An institution eligible to be designated as an infectious disease control institution to take charge of the investigation, diagnosis, isolation, treatment, etc. of patients with infectious diseases, etc. under Article 42 (2) and (5) of the Act, shall be an infectious disease control institution having single-bed hospital rooms (referring to hospital rooms with anterooms and negative pressure isolation facilities) for patients with infectious diseases, etc., from among infectious disease control institutions designated under Article 36 (1) of the Act (hereinafter referred to as "infectious disease control institution").
(2) Where the Minister of Health and Welfare, a City Mayor/Do Governor or the head of a Si/Gun/Gu designates an infectious disease control institution under Article 42 (9) of the Act, he/she shall consider the results of evaluation of infectious disease control facilities prescribed in Article 39-2 of the Act.
(3) Where the Minister of Health and Welfare, a City Mayor/Do Governor or the head of a Si/Gun/Gu designates an infectious disease control institution under Article 42 (9) of the Act, he/she shall issue a certificate of designation as prescribed by the Minister of Health and Welfare.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 24 (Facilities Requiring Disinfection)
Facilities that require disinfection necessary for preventing infectious diseases under Article 51 (2) of the Act, shall be as follows: <Amended by Presidential Decree No. 23356, Dec. 8, 2011; Presidential Decree No. 25448, Jul. 7, 2014; Presidential Decree No. 26024, Jan. 6, 2015; Presidential Decree No. 26916, Jan. 19, 2016; Presidential Decree No. 27277, Jun. 28, 2016; Presidential Decree No. 27445, Aug. 11, 2016; Presidential Decree No. 27971, Mar. 29, 2017>
1. Lodging establishments (limited to those with at least 20 guest rooms) specified in the Public Health Control Act and tourist accommodation establishments specified in the Tourism Promotion Act;
2. Food service business places (hereinafter referred to as “food service establishments”) with a total floor area of at least 300 square meters specified in subparagraph 8 (excluding item (e) thereof) of Article 21 of the Enforcement Decree of the Food Sanitation Act;
3. Intra-city buses, rural buses, shuttle buses, cross-country buses, chartered buses, and funeral coaches specified in the Passenger Transport Service Act; aircraft specified in the Aviation Safety Act and airport facilities specified in the Airport Facilities Act; passenger ships specified in the Marine Transportation Act; waiting lounges with a total floor area of at least 300 square meters specified in the Harbor Act; and rolling stock for passenger transportation, stations, and station facilities specified in the Railroad Service Act and the Urban Railroad Act;
4. Superstores, specialty stores, department stores, shopping centers, multiplex shopping malls, and other large-scale stores specified in the Distribution Industry Development Act, and traditional markets specified in the Special Act on the Development of Traditional Markets and Shopping Districts;
5. General hospitals, hospitals, convalescent hospitals, dental hospitals, and oriental medical hospitals, prescribed in subparagraph 3 of Article 3 of the Medical Service Act;
6. Meal service facilities (limited to those capable of providing meals continuously for at least 100 persons simultaneously) specified in subparagraph 12 of Article 2 of the Food Sanitation Act;
6-2. Food service establishments engaged in catering service business, with a total floor area of at least 300 square meters, specified in subparagraph 8 (e) of Article 21 of the Enforcement Decree of the Food Sanitation Act;
7. Dormitories specified in subparagraph 2 (d) of Table 1 attached to the Enforcement Decree of the Building Act;
7-2. Lodging houses (limited to those to accommodate for at least 50 persons) specified in subparagraph 8 (a) of Table 2 attached to the Enforcement Decree of the Act on Fire Prevention and Installation, Maintenance, and Safety Control of Fire-Fighting Systems;
8. Performance halls (limited to those with a seating capacity of at least 300) specified in the Public Performance Act;
10. Private teaching institutes with a total floor area of at least 1,000 square meters specified in the Act on the Establishment and Operation of Private Teaching Institutes and Extracurricular Lessons;
11. Office buildings and multiple-purpose buildings with a total floor area of at least 2,000 square meters;
12. Nursery facilities specified in the Infant Care Act and kindergartens specified in the Early Childhood Education Act (limited to nursery facilities and kindergartens to accommodate at least 50 persons);
13. Multi-family housing specified in the Multi-Family Housing Management Act (limited to those with at least 300 households).
 Article 25 (Eligibility to Become Epidemic Control Officers, Duties, etc.)
(1) Epidemic control officers specified in Article 60 (1) of the Act, shall be appointed from among public officials of at least Grade IV with substantial experience in a field related to infectious diseases: Provided, That epidemic control officers of each Si/Gun/Gu may be appointed, from among public officials of at least Grade V with substantial experience in a field related to infectious diseases. <Amended by Presidential Decree No. 26865, Jan. 6, 2016>
(2) In addition to the authority to take measures specified in Article 60 (3) of the Act, each epidemic control officer shall have the authority to take the following measures in the outbreak area of an infectious disease: <Amended by Presidential Decree No. 26865, Jan. 6, 2016>
1. Hospitalizing or isolating persons suspected of being affected by the pathogen of an infectious disease for a certain period at an appropriate place;
2. Disinfecting places or buildings contaminated by the pathogen of an infectious disease, or taking other necessary measures;
3. Issuing orders to prohibit laundering at certain places or to handle wastes at designated places;
4. Taking measures to prevent zoonoses, against persons who have involved in slaughter or persons, etc. exposed to zoonoses.
(3) Deleted. <by Presidential Decree No. 26865, Jan. 6, 2016>
 Article 26 (Eligibility to Become Epidemiological Investigative Officers, Duties, etc.)
(1) Deleted. <by Presidential Decree No. 26865, Jan. 6, 2016>
(2) Each epidemiological investigative officer shall perform the following duties:
1. Formulating epidemiological investigation plans;
2. Conducting, and analyzing the findings of, epidemiological investigations;
3. Developing the criteria and methods for conducting epidemiological investigations;
4. Providing technical guidance on epidemiological investigations;
5. Providing education and training on epidemiological investigations;
6. Conducting epidemiological research on infectious diseases.
(3) Deleted. <by Presidential Decree No. 26865, Jan. 6, 2016>
(4) The Minister of Health and Welfare and Mayors/Do Governors may pay research expenses and reimburse travel expenses to epidemiological investigative officers, within budgetary limits.
 Article 26-2 (Ordering Medical Personnel to Conduct Quarantine Duties)
(1) Where the Minister of Health and Welfare or a City Mayor/Do Governor issues an order for conducting quarantine duties under Article 60-3 (1) of the Act, he/she shall issue a certificate of order for conducting quarantine duties. In such cases, the relevant certificate of order shall include the institution to conduct quarantine duties, period of quarantine duties, quarantine duties to be conducted, etc.
(2) The period of quarantine duties prescribed in Article 60-3 (1) of the Act shall not exceed 30 days: Provided, That where the person in question agrees in writing in advance, such period may be determined otherwise.
(3) Where the Minister of Health and Welfare or a City Mayor/Do Governor extends the period of quarantine duties prescribed in paragraph (2), he/she shall obtain written consent from the person in question before the relevant period of quarantine duties expires. In such cases, the period to be extended shall not exceed 30 days, on condition that where the person in question agrees, the period to be extended may be determined otherwise.
(4) Where the Minister of Health and Welfare or a City Mayor/Do Governor extends the period of quarantine duties under paragraph (3), he/she shall issue a new certificate of order for conducting quarantine duties.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 26-3 (Appointment of Epidemic Control Officers)
(1) Where the Minister of Health and Welfare or a City Mayor/Do Governor appoints an epidemic control officer or epidemiological investigation officer under Article 60-3 (2) or (30 of the act, he/she shall issue a certificate of appointment. In such cases, the relevant certificate of appointment shall include the period for conducting duties.
(2) Article 26-2 (2) through (4) shall apply mutatis mutandis to periods for conducting duties, extension of periods for conducting duties, issuance of certificates of appointment following the extension of periods for conducting duties, etc. of epidemic control officers and epidemiological investigation officers.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 27 (Ratio of Subsidy on Part of Cities/Dos)
The amount of expenses subsidized by a City/Do (excluding a Special Self-Governing Province) under Article 66 of the Act shall be 2/3 of the amount to be borne by Sis/Guns/Gus.
 Article 28 (Objects, Scope, etc. of Compensation for Loss)
(1) Objects and scope of compensation for loss prescribed in Article 70 (1) of the Act are as prescribed in attached Table 2-2.
(2) If necessary to calculate the amount of compensation for loss under Article 70 (1) of the Act, the Compensation Deliberation Committee prescribed in Article 70-2 (1) of the Act (hereinafter referred to as the "Deliberation Committee") may have specialized institutions or experts in the relevant areas appraise, evaluate, investigate, etc. the subject-matter of the loss.
(3) Where the Deliberation Committee calculates compensation for the loss in Article 70 (1) 1 through 3 of the Act, it shall consider the annual average revenue, business profits, etc. of the relevant medical institution.
[This Article Wholly Amended by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 28-2 (Exclusion from Payment and Standards for Reducing Compensation for Loss)
(1) The types of misconduct for which compensation for the loss shall not be paid or curtailed on the ground of violating the duty to take measures prescribed by this Act or by the relevant statutes, under Article 70 (3) of the Act, are as follows:
1. Neglecting or interfering with notification and reporting prescribed in Article 11 of the Act or making such notice or report falsely;
2. Neglecting the duty to report prescribed in Article 12 of the Act or interference with reporting of persons obliged to notify prescribed in the subparagraphs of paragraph (1) of the same Article;
3. Engaging in misconduct in conducting an epidemiological investigation prescribed in Article 18 (3) of the Act;
4. Failure in installing infectious disease control facilities prescribed in Article 36 (2) or 37 (2) of the Act;
5. Violating the duty to render cooperation prescribed in Article 60 (4) of the Act;
6. Violating directions and orders prescribed in Article 59 (1) of the Medical Service Act;
7. Violating the duties to make measures the Minister of Health and Welfare publicly announces in recognition that such duties are particularly important among statutory duties to take measures.
(2) Where compensation for loss is not paid or curtailed under Article 70 (3) of the Act, such non-payment or curtailed amount shall be based on whether the misconduct in the subparagraphs of paragraph (1) is directly related to the occurrence or expansion of the loss and whether such misconduct is a major cause of the loss.
(3) Where the Deliberation Committee recognizes the existence of the causal relationship between the misconduct in the subparagraphs of paragraph (1) and the occurrence or expansion of loss under paragraph (2), it shall consider the motives for, details, nature, type, etc. of, the relevant misconduct comprehensively.
(4) The Minister of Health and Welfare shall determine and publicly announce detailed matters necessary for exclusion from payment, standards for payment in reduced amounts, etc. of compensation for loss prescribed in paragraphs (2) and (3).
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 28-3 (Organization and Operation of Compensation Deliberation Committee)
(1) Members of the Deliberation Committee established in the Ministry of Health and Welfare shall be appointed or commissioned by the Minister of Health and Welfare, from among the following persons duly considering gender:
1. Persons recommended by medical personnel organizations and medical institution organizations established under the Medical Service Act, and by the Korean Pharmaceutical Association and the Association of Korean Oriental Pharmacy established under the Pharmaceutical Affairs Act;
2. Persons recommended by organizations recognized by the Minister of Health and Welfare to be closely related to health and medical area as non-profit, non-governmental organizations established under the Assistance for Non-Profit, Non-Governmental Organizations Act;
3. Persons recommended by the President of the National Health Insurance Service under the National Health Insurance Act or by the President of the Health Insurance Review and Assessment Service;
4. Persons holding office or have held office in the position of associate professor or in a position equivalent thereto at health and medical care-related departments of universities prescribed in the Higher Education Act;
5. Persons with abundant knowledge and experience in the prevention and control of infectious diseases;
6. Persons with abundant knowledge and experience in compensation for loss;
7. Public officials belonging to the senior civil service in charge of policies for health and medical care.
(2) The term of office of commissioned members prescribed in paragraph (1) 1 through 6 shall be three years: Provided, That the term of office of members newly commissioned resulting from the dismissal, etc. of another member shall be their predecessor’s remaining term of office.
(3) Where a commissioned member of the Deliberation Committee falls into any of the following cases, the Minister of Health and Welfare may dismiss the relevant commissioned member:
1. Where a commissioned member of the Deliberation Committee becomes unable to conduct his/her duties due to mental or physical disorder;
2. Where a commissioned member of the Deliberation Committee commits any misdeed in connection with his/her duties;
3. Where a commissioned member of the Deliberation Committee is deemed unsuitable to be a member due to neglect of duties, injury to dignity, or any other reason;
4. Where a commissioned member of the Deliberation Committee himself/herself expresses that he/she has difficulties in conducting his/her duties.
(4) The Chairperson of the Deliberation Committee prescribed in paragraph (1) shall represent the Deliberation Committee, and administer the overall affairs of the Deliberation Committee.
(5) Meetings of the Deliberation Committee prescribed in paragraph (1) shall be convened at the request of a majority of members registered or when the Chairperson of the Deliberation Committee deems it necessary, and the Chairperson of the Deliberation Committee shall become the president of such meetings.
(6) Meetings of the Deliberation Committee prescribed in paragraph (1) shall start the deliberation of the bills introduced and pass resolutions by a majority vote of members present.
(7) To efficiently conduct duties, the Deliberation Committee prescribed in paragraph (1) may have advisory committees organized by experts of the relevant areas.
(8) Except as otherwise provided for in paragraphs (1) through (7), matters necessary for the organization, operation, etc. of the Deliberation Committee prescribed in paragraph (1) and advisory committees shall be determined by the Chairperson of the Deliberation Committee through resolutions by the Deliberation Committee.
(9) Paragraphs (1) through (8) shall apply mutatis mutandis to the organization, operation, etc. of deliberation committees established in Cities/Dos under Article 70-2 (1) of the Act. In such cases, the "Minister of Health and Welfare" shall be construed as "City Mayor/Do Governor."
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 28-4 (Providing Subsidies, etc. for Medical Personnel or Founders of Medical Institutions)
(1) The Minister of Health and Welfare, every City Mayor/Do Governor or the head of each Si/Gun/Gu may provide medical personnel or founders of medical institutions which have rendered assistance for the surveillance, prevention, control or epidemiological investigation of infectious diseases under Article 70-3 (1) of the Act with subsidies to cover allowances, travel expenses, etc.
(2) Any person who intends to receive subsidies prescribed in paragraph (1) shall file an application with the Minister of Health and Welfare, the City Mayor/Do Governor or the head of the Si/Gun/Gu along with materials evidencing that he/she has rendered assistance for the surveillance, prevention and control of infectious diseases and for epidemiological investigative affairs.
(3) Upon receipt of an application for subsidies prescribed in paragraph (2), the Minister of Health and Welfare, the City Mayor/Do Governor or the head of the Si/Gun/Gu shall determine the possibility of providing subsidies, items of subsidies, amount of subsidies etc. and inform the applicant thereof.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 28-5 (Livelihood Assistance, etc. for Patients with Infectious Diseases, etc.)
The Minister of Health and Welfare, City Mayor/Do Governors or the heads of Sis/Guns/Gus may provide the following subsidies under Article 70-4 (1) of the Act: Provided, That no subsidies prescribed in subparagraph 2 shall be provided where paid leave is given under Article 41-2 (1) of the Act:
1. Medical costs and hospitalization costs: The medical costs and hospitalization costs to be borne by the person in question: Provided, That costs prescribed by the Minister of Health and Welfare, such as costs excluded from costs eligible to be covered by convalescent benefits prescribed by the National Health Insurance Act, shall be excluded;
2. Costs for supporting livelihood: The amount the Minister of Health and Welfare publicly announces after consulting with the Minister of Strategy and Finance.
[This Article Newly Inserted by Presidential Decree No. 27277, Jun. 28, 2016]
 Article 29 (Compensation Standards for Injuries Caused by Vaccination, etc.)
Standards for payment of compensation under Article 71 (1) of the Act, shall be as follows: <Amended by Presidential Decree No. 26024, Jan. 6, 2015>
1. Medical expenses: The balance of the medical expenses for a disease contracted by an injury resulting from vaccination, less the amount borne or paid by an insurer under the National Health Insurance Act, or less the amount borne by the medical care fund under the Medical Care Assistance Act: Provided, That when the lump-sum compensation is paid under subparagraph 3, no medical expenses shall be paid;
2. Nursing expenses: 50,000 won per day only for inpatient treatment;
3. Lump-sum compensation for those who become disabled: An amount determined based upon the disability rating under the Act on Welfare of Persons with Disabilities, as follows:
(a) A person with a grade-1 disability: 100/100 of the lump-sum compensation for death;
(b) A person with a grade-2 disability: 85/100 of the lump-sum compensation for death;
(c) A person with a grade-3 disability: 70/100 of the lump-sum compensation for death;
(d) A person with a grade-4 disability: 55/100 of the lump-sum compensation for death;
(e) A person with a grade-5 disability: 40/100 of the lump-sum compensation for death;
(f) A person with a grade-6 disability: 25/100 of the lump-sum compensation for death;
4. Lump-sum compensation for death: An amount equivalent to the monthly minimum wage under the Minimum Wage Act as at the time of death, multiplied by 240;
5. Funeral expenses: 300,000 won.
 Article 29 (Compensation Standards for Injuries Caused by Vaccination, etc.)
Standards for payment of compensation under Article 71 (1) of the Act shall be as follows: <Amended by Presidential Decree No. 26024, Jan. 6, 2015; Presidential Decree No. 28070, May 29, 2017>
1. Medical expenses: The balance of the medical expenses for a disease contracted by an injury resulting from vaccination, less the amount borne or paid by an insurer under the National Health Insurance Act, or less the amount borne by the medical care fund under the Medical Care Assistance Act: Provided, That when the lump-sum compensation is paid under subparagraph 3, no medical expenses shall be paid;
2. Nursing expenses: 50,000 won per day only for inpatient treatment;
3. Lump-sum compensation for those who become disabled:
(a) Persons with disabilities prescribed under the Act on Welfare of Persons with Disabilities:
(i) A person with a grade-1 disability: 100/100 of the lump-sum compensation for death;
(ii) A person with a grade-2 disability: 85/100 of the lump-sum compensation for death;
(iii) A person with a grade-3 disability: 70/100 of the lump-sum compensation for death;
(iv) A person with a grade-4 disability: 55/100 of the lump-sum compensation for death;
(v) A person with a grade-5 disability: 40/100 of the lump-sum compensation for death;
(vi) A person with a grade-6 disability: 25/100 of the lump-sum compensation for death;
(b) In cases of persons who fall into the grades of disability or grades of personal damage prescribed in the Acts the Minister of Health and Welfare determines and publicly announces, such as the National Pension Act, the Public Officials Pension Act, and the Industrial Accident Compensation Insurance Act; the amount the Minister of Health and Welfare determines and publicly announces by standard for the relevant grade of disability or personal damage within the scope of 20/100 of the limp-sum compensation for death;
4. Lump-sum compensation for death: An amount equivalent to the monthly minimum wage prescribed under the Minimum Wage Act as at the time of death, multiplied by 240;
5. Funeral expenses: 300,000 won.
<<Enformenet Date : Jan. 1, 2018>> subpargraph 3 of Article 29
 Article 30 (Persons Eligible for Compensation for Injuries Caused by Vaccination, etc.)
(1) A person eligible for compensation under Article 71 (1) of the Act, shall be as follows:
1. For cases falling under Article 71 (1) 1 and 2 of the Act: Victims;
2. For cases falling under Article 71 (1) 3 of the Act: Bereaved family members determined based on the order of priority.
(2) “Bereaved family members prescribed by Presidential Decree” in Article 71 (1) 3 of the Act, means the spouse (including a person in a de facto marital relationship), children, parents, grandsons and granddaughters, grandparents, and siblings.
(3) The priority order of bereaved family members shall coincide with the order listed in paragraph (2), excluding those to whom the compensation cannot be provided due to missing, etc.; and if at least two bereaved family members are in the same order of priority, the lump-sum compensation for death shall be apportioned equally among them.
 Article 31 (Compensation Procedures for Injuries Caused by Vaccination, etc.)
(1) Any person who intends to receive compensation under Article 71 (1) of the Act shall submit a written claim for compensation to the competent Special Self-Governing Province Governor or head of Si/Gun/Gu, along with a document evidencing his/her injury, as prescribed by Ordinance of the Ministry of Health and Welfare.
(2) The head of a Si/Gun/Gu shall submit documents received under paragraph (1) (hereinafter referred to as “claim documents for injury compensation”) to the competent Mayor/Do Governor, and the Mayor/Do Governor in receipt of the claim documents for injury compensation or the Special Self-Governing Province Governor in receipt of the claim documents for injury compensation under paragraph (1), shall forward the claim documents for injury compensation without delay to the Minister of Health and Welfare, along with the findings of basic investigation conducted by him/her regarding the injury that has resulted from vaccination and the statement of his/her views thereon.
(3) The Minister of Health and Welfare shall determine whether to provide compensation after gather consensus from the advisory committee on vaccination injury compensation and notify the relevant Mayor/Do Governor of the determination, and the Mayor/Do Governor (excluding a Special Self-Governing Province Governor) shall notify the head of the relevant Si/Gun/Gu thereof. In such cases, the Special Self-Governing Province Governor or the head of the Si/Gun/Gu so notified shall notify the relevant claimant for compensation under paragraph (1) of the details of the determination. <Amended by Presidential Decree No. 26024, Jan. 6, 2015>
(4) The Minister of Health and Welfare shall pay a person determined eligible for compensation under paragraph (3) the amount of compensation under the compensation standards under Article 29.
(5) Except as otherwise expressly provided for in this Decree, matters necessary for the procedures and methods for deliberation on compensation for injuries caused by vaccination shall be determined by the Minister of Health and Welfare.
 Article 32 (Delegation of Authority and Entrustment of Duties)
(1) The Minister of Health and Welfare shall delegate the following authority to the Director of the Korea Centers for Disease Control and Prevention, pursuant to Article 76 (1) of the Act: <Amended by Presidential Decree No. 26024, Jan. 6, 2015; Presidential Decree No. 26865, Jan. 6, 2016; Presidential Decree No. 27277, Jun. 28, 2016>
1. The following affairs concerning the organization for supporting infectious disease control projects established in the Ministry of Health and Welfare under Article 8 (1) of the Act:
(a) Affairs concerning commissioning members prescribed in Article 1-2 (2);
(b) Affairs concerning reporting prescribed in Article 1-2 (4);
(c) Affairs concerning providing subsidies prescribed in Article 1-2 (5);
1-2. Affairs concerning designating, operating and subsidizing regional infectious disease hospitals prescribed in Article 8-2 (2) and (3) of the Act and Article 1-4 of this Decree;
1-3. Affairs concerning operating advisory committees established under Article 10 (3) of the Act;
2. Affairs concerning reporting on infectious diseases prescribed in Article 11 (3) and (5) of the Act;
3. Affairs concerning reporting by a Special Self-Governing Province Governor or the head of a Si/Gun/Gu under Article 13 of the Act;
4. Affairs concerning the sentinel surveillance, etc. of infectious diseases conducted under Article 16 of the Act;
5. Affairs concerning fact-finding surveys conducted under Article 17 of the Act;
5-2. Affairs concerning requests for epidemiological investigation prescribed in Article 18-2 (1) and (2) of the Act;
5-3. Affairs concerning fostering personnel for epidemiological investigation prescribed in Article 18-3 (1) of the Act;
5-4. Affairs concerning submitting materials necessary for epidemiological investigation and affairs concerning requests for providing assistance, such as dispatching personnel for conducting epidemiological investigation, which are prescribed in Article 18-4 (1) and (2) of the Act;
5-5. Affairs concerning funerals for the dead bodies of patients with infectious diseases, etc. prescribed in Article 20-2 of the Act;
6. Affairs concerning reporting on extraction and transfer of high-risk pathogens under Article 21 of the Act;
7. Affairs concerning permits, etc. to introduce high-risk pathogens under Article 22 of the Act;
8. Affairs concerning the safety management of high-risk pathogens under Article 23 of the Act;
9. Affairs concerning requests for special vaccinations under Article 25 (1) 1 of the Act;
10. Affairs concerning reporting on records on vaccinations under Article 28 of the Act;
11. Affairs concerning Vaccination Week, standards for conducting vaccinations, etc. specified under Article 32 of the Act;
12. Affairs concerning the planned production of vaccines, provision of subsidies, and reimbursement of expenses under Article 33 of the Act;
12-2. Affairs concerning establishing and operating the integrated management system; collecting, managing and keeping materials; requesting submission of materials; providing details of vaccination; issuing certificates of vaccination; and requesting for materials from the head of the National Court Administration, which are prescribed in Article 33-2 (1), (2) and (4) of the Act;
13. Affairs concerning establishing, etc. infectious disease control institutions as at the time of infectious disease emergencies under Article 37 of the Act;
13-2. Affairs concerning evaluating infectious disease control facilities prescribed in Article 39-2 of the Act;
14. Affairs concerning the stockpiling of, conclusion of contracts for, requirement for production of, and epidemiological investigations into, medicines and equipment for infectious diseases, etc. spread by biological terrorism under Article 40 of the Act;
14-2. Affairs concerning the distribution standards including priorities in supplying medicines stockpiled and produced in preparation for a pandemic of infectious diseases and other necessary matters prescribed in Article 40-2 of the Act;
15. Affairs concerning controling patients, etc. with infectious diseases under Article 41 of the Act;
16. Affairs concerning making compulsory dispositions with respect to infectious diseases under Article 42 of the Act;
17. Affairs concerning giving hospitalization notice to patients, etc. with infectious diseases under Article 43 of the Act;
17-2. Affairs concerning measures to conduct medical examinations, vaccinations, etc. under Article 46 of the Act;
17-3. Affairs concerning measures to prevent the prevalence or spread of an infectious disease upon the outbreak of the infectious disease under Article 47 of the Act;
17-4. Affairs concerning measures to prevent an infectious disease under Article 49 of the Act;
18. Affairs concerning epidemic control officers and epidemiological investigative officers appointed under Articles 60 and 60-2 of the Act;
18-2. Affairs concerning orders for conducting quarantine duties, and appointment and management of epidemic control officers and epidemiological investigation officers prescribed in Article 60-3 (1) through (3) of the Act;
19. Affairs concerning providing subsidies prescribed in Article 70-3 (1) of the Act;
19-2. Administrative affairs concerning medical costs, livelihood assistance and providing subsidies prescribed in Article 70-4 (1) of the Act;
20. Affairs concerning compensation by the State for injuries caused by vaccinations, etc. under Article 71 of the Act.
20-2. Affairs concerning requests for location information; providing information collected; and information and notification of destruction of information provided by persons provided with such information prescribed in Article 76-2 (2) through (5) of the Act.
(2) The Minister of Health and Welfare may entrust the duties provided for in Article 4 (2) 4 through 9 and 14 through 17 of the Act to any of the following entities, pursuant to Article 76 (2) of the Act: <Newly Inserted by Presidential Decree No. 26024, Jan. 6, 2015; Presidential Decree No. 26865, Jan. 6, 2016>
1. Government-funded research institutes established under the Act on the Establishment, Operation and Fostering of Government-Funded Research Institutes, Etc.;
3. Non-profit corporations established under the Civil Act or other Acts to conduct affairs concerning the prevention and control of infectious diseases;
4. Other institutions or organizations deemed by the Minister of Health and Welfare to have expertise in the prevention and control of infectious diseases.
(3) Where the Minister of Health and Welfare entrusts duties pursuant to paragraph (2), he/she shall publicly announce the entities and details of duties entrusted. <Newly Inserted by Presidential Decree No. 26024, Jan. 6, 2015>
 Article 32-2 (Information Requestable to be Provided)
“Information prescribed by Presidential Decree” in Article 76-2 (1) 4 of the Act, means the following:
1. Credit card, debit card, and pre-paid card statements defined in subparagraphs 3, 6, and 8 of Article 2 of the Specialized Credit Finance Business Act;
3. Image data compiled through image data processing equipment defined in subparagraph 7 of Article 2 of the Personal Information Protection Act.
[This Article Newly Inserted by Presidential Decree No. 26865, Jan. 6, 2016]
 Article 32-3 (Processing Sensitive Personal Information and Personally Identifiable Information)
(1) The State and local governments (including any person to whom relevant authority is delegated or entrusted) may process data containing information on health prescribed in Article 23 of the Personal Information Protection Act and resident registration numbers or foreigner registration numbers prescribed in subparagraph 1 or 4 of Article 19 of the Enforcement Decree of the same Act, in extenuating circumstances to conduct the following:
1. Medical treatment and protection of patients, etc. with infectious diseases under Article 4 (2) 2 of the Act;
2. Training experts for the prevention of infectious diseases under Article 4 (2) 8 of the Act;
3. International cooperation for the exchange, etc. of infectious disease control information under Article 4 (2) 9 of the Act.
(2) The Minister of Health and Welfare, the Director of the Korea Centers for Disease Control and Prevention, the Mayors/Do Governors, the heads of Sis/Guns/Gus (including any medical institution entrusted with vaccination services by the head of a Si/Gun/Gu under Article 20), the heads of public health clinics, or the institutions of sentinel surveillance of infectious diseases designated under Article 16 (1) of the Act, may process data containing personal information prescribed in the main sentence of paragraph (1), in extenuating circumstances, to conduct the following: <Amended by Presidential Decree No. 27277, Jun. 28, 2016>
1. Notification, reporting, detection, and control of patients, etc. with infectious diseases under Articles 11 through 13 and 15 of the Act;
2. Sentinel surveillance, etc. of infectious diseases under Article 16 of the Act;
3. Fact-finding surveys conducted under Article 17 of the Act;
4. Epidemiological investigations conducted under Article 18 of the Act;
5. Medical examinations conducted under Article 19 of the Act;
6. Autopsy orders issued under Article 20 of the Act;
7. High-risk pathogens specified in Articles 21 through 23 of the Act;
9. Designation of infectious disease control institutions and the establishment and operation of infectious disease control facilities, isolation wards, sanatoriums, and clinics, under Articles 36 and 37 of the Act;
10. Control of patients, etc. with infectious diseases and quarantine and preventive measures against infectious diseases, under Articles 41 through 43, 45 through 47, 49, and 50 of the Act;
11. Reporting on disinfection services under Articles 52 and 53 of the Act;
12. Training for disinfection service providers, etc. under Article 55 of the Act;
13. Compensation for loss and compensation by the State for injuries caused by vaccinations, etc. under Articles 70 through 72 of the Act.
[This Article Newly Inserted by Presidential Decree No. 25532, Aug. 6, 2014]
 Article 33 (Imposition of Administrative Fines)
Standards for imposing administrative fines under Article 83 (1) of the Act, shall be specified in attached Table 3.
[This Article Wholly Amended by Presidential Decree No. 26865, Jan. 6, 2016]
ADDENDA
Article 1 (Enforcement Date)
This Decree shall enter into force on December 30, 2010: Provided, That Article 7 (11) of the Addenda shall enter into force on January 1, 2011.
Article 2 (Applicability to Standards for Compensating Nursing Expenses)
The amended provisions of subparagraph 2 of Article 29 shall begin to apply from the first nursing expenses reimbursed after this Decree enters into force.
Article 3 (Transitional Measures concerning Institutions Entrusted with Vaccination Services)
Any institution entrusted with vaccination services under the former Enforcement Decree of the Prevention of Contagious Diseases Act as at the time this Decree enters into force, shall be deemed an institution entrusted with vaccination services under the amended provisions of Article 20 (1).
Article 4 (Transitional Measures concerning Official Title of Epidemic Control Officer)
Epidemic control officials and epidemic control officers appointed under the former Enforcement Decree of the Prevention of Contagious Diseases Act as at the time this Decree enters into force, shall be deemed epidemic control officers appointed under the amended provisions of Article 25.
Article 5 (Transitional Measures concerning Eligibility for Epidemiological Investigative Officers)
Any epidemiological investigative officer appointed under the former Enforcement Decree of the Prevention of Contagious Diseases Act as at the time this Decree enters into force, shall be deemed qualified as an epidemiological investigative officer under the amended provisions of Article 26 (1).
Article 6 (Transitional Measures concerning Administrative Fines)
(1) The imposition of an administrative fine for any offense committed before this Decree enters into force, shall be subject to standards for imposing administrative fines for the first offense under the amended provisions of attached Table 3.
(2) No disposition to impose an administrative fine taken against any offense before this Decree enters into force, shall be included in calculating the frequency of offenses committed under the amended provisions of attached Table 3.
Article 7 Omitted.
Article 8 (Relationship with other Statutes)
Any citation of the former Enforcement Decree of the Prevention of Contagious Diseases Act or of any provision thereof, in any other statute, as at the time this Decree enters into force, shall be deemed a citation of this Decree or of the relevant provision hereof, if such provision corresponding thereto exists in this Decree, in lieu of the former provisions.
ADDENDA <Presidential Decree No. 23356, Dec. 8, 2011>
Article 1 (Enforcement Date)
This Decree shall enter into force on December 8, 2011. (Proviso Omitted.)
Article 2 Omitted.
ADDENDA <Presidential Decree No. 24454, Mar. 23, 2013>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation. (Proviso Omitted.)
Articles 2 through 4 Omitted.
ADDENDA <Presidential Decree No. 25448, Jul. 7, 2014>
Article 1 (Enforcement Date)
This Decree shall enter into force on July 8, 2014.
Articles 2 through 4 Omitted.
ADDENDUM <Presidential Decree No. 25532, Aug. 6, 2014>
This Decree shall enter into force on August 7, 2014.
ADDENDUM <Presidential Decree No. 26024, Jan. 6, 2015>
This Decree shall enter into force six months after the date of its promulgation.
ADDENDUM <Presidential Decree No. 26865, Jan. 6, 2016>
This Decree shall enter into force on January 7, 2016.
ADDENDA <Presidential Decree No. 26916, Jan. 19, 2016>
Article 1 (Enforcement Date)
This Decree shall enter into force on January 21, 2016. (Proviso Omitted.)
Articles 2 through 4 Omitted.
ADDENDUM <Presidential Decree No. 27277, Jun. 28, 2016>
This Decree shall enter into force on June 30, 2016.
ADDENDA <Presidential Decree No. 27445, Aug. 11, 2016>
Article 1 (Enforcement Date)
This Decree shall enter into force on August 12, 2016.
Articles 2 through 22 Omitted.
ADDENDA <Presidential Decree No. 27971, Mar. 29, 2017>
Article 1 (Enforcement Date)
This Decree shall enter into force on March 30, 2017. (Proviso Omitted.)
Articles 2 through 11 Omitted.
ADDENDA <Presidential Decree No. 28070, May 29, 2017>
Article 1 (Enforcement Date)
This Decree shall enter into force on June 3, 2017: Provided, That the amended provisions of subparagraph 3 of Article 29 shall enter into force on January 1, 2018.
Article 2 (Applicability to Compensation for Damage Caused by Vaccination, etc.)
The amended provisions of subparagraph 3 of Article 29 shall begin to apply from those vaccinated under Articles 24 and 25 of the Act or administered with preventive or therapeutic medicines produced under Article 40 (2) of the Act after the enforcement date in the proviso to Article 1 of Addenda.